Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.18342 | 48 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.23802 | 51 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.23103 | 51 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.17481 | 51 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.17486 | 51 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.34095 | 51 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.30039 | 51 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.88319 | 65 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.21891 | 51 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.23406 | 52 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.22724 | 51 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.4661 | 58 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.30815 | 53 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.24328 | 52 |